Blood-Test Customers Mistakenly Told They May Have Cancer

  • 📰 WSJ
  • ⏱ Reading Time:
  • 22 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 63%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

About 400 people who signed up for a cancer-detection blood test from Grail were incorrectly told they may have the disease, according to the company, which blamed the mistakes on a partner’s software glitch

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.

Grail said its telemedicine vendor sent inaccurate forms because of a software glitchGrail, a developer of multi-cancer early-detection blood tests, says about 400 customers were notified mistakenly that they may have the disease.Cancer blood-test maker Grail said about 400 customers were mistakenly notified that its test detected a cancer signal in them, which the company attributed to a partner’s software glitch.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 98. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Grail says about 400 patients incorrectly informed they may have cancerCancer test maker Grail Inc said on Friday that its telemedicine vendor erroneously sent letters to about 400 patients suggesting they may have developed cancer.
Source: Reuters - 🏆 2. / 97 Read more »

Software snafu leads to 400 Grail patients getting bogus letters saying they might have cancerGrail, owned by San Diego's Illumina, said erroneous letters were triggered by a software problem at a third-party telemedicine vendor. Patients have been contacted alerting them that the notification was inaccurate
Source: sdut - 🏆 5. / 95 Read more »

Multi-cancer blood test shows real promise in NHS studyThe Galleri test revealed the correct site of a tumour 85% of the time in a study with 5,000 patients.
Source: bbchealth - 🏆 143. / 63 Read more »